Risk factors and treatment outcomes of childhood stroke

Expert Review of Neurotherapeutics

Volumn 10, Issue 8, 2010, Pages 1331-1346

  Mallick, Andrew A ^a   Ocallaghan, Finbar J K ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

cerebral infarction; intracranial hemorrhage; outcome; prognosis; risk factors; stroke; treatment

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; ANTIVITAMIN K; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CHILDHOOD DISEASE; CHILDHOOD MORTALITY; COGNITION; EDUCATIONAL STATUS; EVIDENCE BASED MEDICINE; GENETIC ALGORITHM; HEART DISEASE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; MORBIDITY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; QUALITY OF LIFE; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; STROKE; SURVIVOR; TREATMENT OUTCOME;

ADULT; AGE FACTORS; CHILD; GENETIC DISEASES, INBORN; HEART DISEASES; HEMATOLOGIC DISEASES; HUMANS; INFECTION; PEDIATRICS; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 77955062645     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/ern.10.106     Document Type: Review

References (214)

1. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367(9524), 1747-1757 (2006).
2. Liu M. Stroke: encouragement and disappointment in clinical trials. Lancet Neurol. 7(1), 5-7 (2008).
3. Bogousslavsky J, Paciaroni M. The economics of treating stroke as an acute brain attack. BMC Med. 7, 51 (2009).
4. Saver JL. Time is brain-quantifed. Stroke 37(1), 263-266 (2006).
5. Wehrmacher WH, Iqbal O, Messmore H. Brain attack: who will write the orders for thrombolytics? Arch. Intern. Med. 160(1), 119-120 (2000).
6. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst. Rev. 4, CD000213 (2009).
7. Kirkham F, Sebire G, Steinlin M, Strater R. Arterial ischaemic stroke in children. Review of the literature and strategies for future stroke studies. Thromb. Haemost. 92(4), 697-706 (2004).
8. Mallick AA, O'Callaghan FJ. The epidemiology of childhood stroke. Eur. J. Paediatr. Neurol. 14(3), 197-205 (2009).
9. Stiller CA. Epidemiology and genetics of childhood cancer. Oncogene 23(38), 6429-6444 (2004).
10. Jordan LC. Stroke in childhood. Neurologist 12(2), 94-102 (2006).
11. Rosamond W, Flegal K, Furie K et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117(4), E25-E146 (2008).
12. Ganesan V, Hogan A, Shack N, Gordon A, Isaacs E, Kirkham FJ. Outcome after ischaemic stroke in childhood. Dev. Med. Child. Neurol. 42(7), 455-461 (2000).
13. Fullerton HJ, Wu YW, Sidney S, Johnston SC. Recurrent hemorrhagic stroke in children: a population-based cohort study. Stroke 38(10), 2658-2662 (2007).
14. Fullerton HJ, Wu Y W, Sidney S, Johnston SC. Risk of recurrent childhood arterial ischemic stroke in a population-based cohort: the importance of cerebrovascular imaging. Pediatrics 119(3), 495-501 (2007).
15. McGlennan C, Ganesan V. Delays in investigation and management of acute arterial ischaemic stroke in children. Dev. Med. Child. Neurol. 50(7), 537-540 (2008).
16. Rafay MF, Pontigon AM, Chiang J et al. Delay to diagnosis in acute pediatric arterial ischemic stroke. Stroke 40(1), 58-64 (2009).
17. Chambliss S. US Senate Resolution 184-A resolution expressing the sense of the Senate with respect to childhood stroke and designating May 5, 2007, as 'National Childhood Stroke Awareness Day'. The Library of Congress, Washington, DC, USA (2007)
18. World Health Organization. Cerebrovascular Disorders: a Clinical and Research Classifcation. WHO, Geneva, Switzerland (1978).
19. Sudlow CL, Warlow CP. Comparing stroke incidence worldwide: what makes studies comparable? Stroke 27(3), 550-558 (1996).
20. Kirton A, Schechter T, Brandao L et al. Hemorrhagic transformation of arterial ischaemic stroke in children. J. Thromb. Haemost. 5(Suppl. 1), P-T-592 (2007).
21. Jordan LC, Hillis AE. Hemorrhagic stroke in children. Pediatr. Neurol. 36(2), 73-80 (2007).
22. Cnossen MH, van Ommen CH, Appel IM. Etiology and treatment of perinatal stroke; a role for prothrombotic coagulation factors? Semin. Fetal Neonatal Med. 14(5), 311-317 (2009).
23. Kirton A, Deveber G, Pontigon AM, Macgregor D, Shroff M. Presumed perinatal ischemic stroke: vascular classifcation predicts outcomes. Ann. Neurol. 63(4), 436-443 (2008).
24. Nelson KB, Lynch JK. Stroke in newborn infants. Lancet Neurol. 3(3), 150-158 (2004).
25. Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J. Child. Neurol. 8(3), 250-255 (1993).
26. Fullerton HJ, Wu Y W, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology 61(2), 189-194 (2003).
27. Giroud M, Lemesle M, Gouyon JB, Nivelon JL, Milan C, Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J. Clin. Epidemiol. 48(11), 1343-1348 (1995).
28. Agrawal N, Johnston SC, Wu Y W, Sidney S, Fullerton HJ. Imaging data reveal a higher pediatric stroke incidence than prior US estimates. Stroke 40(11), 3415-3421 (2009).
29. Lynch JK, Nelson KB. Epidemiology of perinatal stroke. Curr. Opin. Pediatr. 13(6), 499-505 (2001).
30. Barnes C, Newall F, Furmedge J, Mackay M, Monagle P. Arterial ischaemic stroke in children. J. Paediatr. Child Health 40(7), 384-387 (2004).
31. deVeber G. The Canadian Pediatric Ischemic Stroke Study Group: Canadian paediatric ischemic stroke registry: analysis of children with arterial ischemic stroke [abstract]. Ann. Neurol. 48, 514 (2000).
32. Kirkham FJ, Williams AN, Aylett S, Ganesan V. Cerebrovascular disease/stroke and like illness. In: British Paediatric Surveillance Unit, 17th Annual Report. Royal College of Paediatrics and Child Health, London, UK, 10-12 (2003).
33. Steinlin M, Pfster I, Pavlovic J et al. The frst three years of the Swiss Neuropaediatric Stroke Registry (SNPSR): a population-based study of incidence, symptoms and risk factors. Neuropediatrics 36(2), 90-97 (2005).
34. Mallick AA, Ganesan V, O'Callaghan FJ. Mortality from childhood stroke in England and Wales, 1921-2000. Arch. Dis. Child. 95(1), 12-19 (2010).
35. Fullerton HJ, Chetkovich DM, Wu Y W, Smith WS, Johnston SC. Deaths from stroke in US children, 1979 to 1998. Neurology 59(1), 34-39 (2002).
36. Chung B, Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 114(2), E206-E212 (2004).
37. Golomb MR, Fullerton HJ, Nowak-Gottl U, Deveber G. Male predominance in childhood ischemic stroke: fndings from the international pediatric stroke study. Stroke 40(1), 52-57 (2009).
38. Williams AN, Eunson PD, McShane MA, Lynn R, Green SH, Kirkham F. Childhood cerebrovascular disease and stroke like illness in the United Kingdom and Eire. A descriptive epidemiological study. Arch. Dis. Child. 86(Suppl. 1), A40-A41 (G113) (2002).
39. Reeves MJ, Bushnell CD, Howard G et al. Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol. 7(10), 915-926 (2008).
40. Normann S, de Veber G, Fobker M et al. Role of endogenous testosterone concentration in pediatric stroke. Ann. Neurol. 66(6), 754-758 (2009).
41. Du L, Bayir H, Lai Y et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J. Biol. Chem. 279(37), 38563-38570 (2004).
42. Fullerton HJ, Johnston SC, Smith WS. Arterial dissection and stroke in children. Neurology 57(7), 1155-1160 (2001).
43. Fullerton HJ. Excess stroke risk in black and hispanic children: a popluation based study. Stroke 38(2), 460 (2007).
44. Kleindorfer D. Sociodemographic groups at risk: race/ethnicity. Stroke 40(3 Suppl.), S75-S78 (2009).
45. Howard TD, Giles WH, Xu J et al. Promoter polymorphisms in the nitric oxide synthase 3 gene are associated with ischemic stroke susceptibility in young black women. Stroke 36(9), 1848-1851 (2005).
46. Williams LS, Garg BP, Cohen M, Fleck JD, Biller J. Subtypes of ischemic stroke in children and young adults. Neurology 49(6), 1541-1545 (1997).
47. Biller J. Stroke in Children and Young Adults. Saunders, PA, USA (2009).
48. Mackay MT, Wiznitzer M, Benedict SL et al. Presumptive risk factors in children with arterial ischaemic stroke: results from the International Pediatric Stroke Study [abstract]. Stroke 41(4), E216 (2010).
49. Amlie-Lefond C, Sebire G, Fullerton HJ. Recent developments in childhood arterial ischaemic stroke. Lancet Neurol. 7(5), 425-435 (2008). (Pubitemid 351509423)
50. De Ribaupierre S, Rilliet B, Cotting J, Regli L. A 10-year experience in paediatric spontaneous cerebral hemorrhage: which children with headache need more than a clinical examination? Swiss Med. Wkly 138(5-6), 59-69 (2008).
51. Ganesan V, Prengler M, McShane MA, Wade AM, Kirkham FJ. Investigation of risk factors in children with arterial ischemic stroke. Ann. Neurol. 53(2), 167-173 (2003).
52. Lee YY, Lin KL, Wang HS et al. Risk factors and outcomes of childhood ischemic stroke in Taiwan. Brain Dev. 30(1), 14-19 (2008).
53. Blom I, De Schryver EL, Kappelle LJ, Rinkel GJ, Jennekens-Schinkel A, Peters AC. Prognosis of haemorrhagic stroke in childhood: a long-term follow-up study. Dev. Med. Child. Neurol. 45(4), 233-239 (2003).
54. Kenet G, Lutkhoff LK, Albisetti M et al. Impact of thrombophilia on risk of arterial ischemic stroke or cerebral sinovenous thrombosis in neonates and children: a systematic review and meta-analysis of observational studies. Circulation 121(16), 1838-1847 (2010).
55. Djordjevic V, Stankovic M, Brankovic-Sreckovic V, Rakicevic L, Radojkovic D. Genetic risk factors for arterial ischemic stroke in children: a possible MTHFR and eNOS gene-gene interplay? J. Child. Neurol. 24(7), 823-827 (2009).
56. Lanthier S, Carmant L, David M, Larbrisseau A, de Veber G. Stroke in children: the coexistence of multiple risk factors predicts poor outcome. Neurology 54(2), 371-378 (2000).
57. Amlie-Lefond C, Bernard TJ, Sebire G et al. Predictors of cerebral arteriopathy in children with arterial ischemic stroke: results of the International Pediatric Stroke Study. Circulation 119(10), 1417-1423 (2009).
58. Sebire G, Fullerton H, Riou E, deVeber G. Toward the defnition of cerebral arteriopathies of childhood. Curr. Opin. Pediatr. 16(6), 617-622 (2004).
59. Chabrier S, Rodesch G, Lasjaunias P, Tardieu M, Landrieu P, Sebire G. Transient cerebral arteriopathy: a disorder recognized by serial angiograms in children with stroke. J. Child. Neurol. 13(1), 27-32 (1998).
60. Danchaivijitr N, Cox TC, Saunders DE, Ganesan V. Evolution of cerebral arteriopathies in childhood arterial ischemic stroke. Ann. Neurol. 59(4), 620-626 (2006).
61. Braun K P, Bulder MM, Chabrier S et al. The course and outcome of unilateral intracranial arteriopathy in 79 children with ischaemic stroke. Brain 132(Pt 2), 544-557 (2009).
62. Sebire G, Meyer L, Chabrier S. Varicella as a risk factor for cerebral infarction in childhood: a case-control study. Ann. Neurol. 45(5), 679-680 (1999).
63. Askalan R, Laughlin S, Mayank S et al. Chickenpox and stroke in childhood: a study of frequency and causation. Stroke 32(6), 1257-1262 (2001).
64. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology 64(4), 660-663 (2005).
65. Ribai P, Liesnard C, Rodesch G et al. Transient cerebral arteriopathy in infancy associated with enteroviral infection. Eur. J. Paediatr. Neurol. 7(2), 73-75 (2003).
66. Guidi B, Bergonzini P, Crisi G, Frigieri G, Portolani M. Case of stroke in a 7-year-old male after parvovirus B19 infection. Pediatr. Neurol. 28(1), 69-71 (2003).
67. Leonardi S, Pavone P, Rotolo N, La Rosa M. Stroke in two children with Mycoplasma pneumoniae infection. A causal or casual relationship? Pediatr. Infect. Dis. J. 24(9), 843-845 (2005).
68. Renard C, Marignier S, Gillet Y et al. Acute hemiparesis revealing a neuroborreliosis in a child. Arch. Pediatr. 15(1), 41-44 (2008).
69. Nagra A, Saleem MA, Ramanan AV. The disease with a thousand faces. Arch. Dis. Child. Ed. Pract. 91(1), EP14-EP19 (2006).
70. Belman AL, Leicher CR, Moshe SL, Mezey A P. Neurologic manifestations of Schoenlein-Henoch purpura: report of three cases and review of the literature. Pediatrics 75(4), 687-692 (1985).
71. von Scheven E, Lee C, Berg BO. Pediatric Wegener's granulomatosis complicated by central nervous system vasculitis. Pediatr. Neurol. 19(4), 317-319 (1998).
72. Morfn-Maciel B, Medina A, Espinosa Rosales F, Berron R, Huerta Lopez J. Central nervous system involvement in a child with polyarteritis nodosa and severe atopic dermatitis. Rev. Alerg. Mex. 49(6), 189-195 (2002).
73. Cantu C, Pineda C, Barinagarrementeria F et al. Noninvasive cerebrovascular assessment of Takayasu arteritis. Stroke 31(9), 2197-2202 (2000).
74. Tabarki B, Mahdhaoui A, Selmi H, Yacoub M, Essoussi AS. Kawasaki disease with predominant central nervous system involvement. Pediatr. Neurol. 25(3), 239-241 (2001).
75. Benseler SM, Silverman E, Aviv RI et al. Primary central nervous system vasculitis in children. Arthritis Rheum. 54(4), 1291-1297 (2006).
76. Elbers J, Benseler SM. Central nervous system vasculitis in children. Curr. Opin. Rheumatol. 20(1), 47-54 (2008).
77. Aviv RI, Benseler SM, Silverman ED et al. MR imaging and angiography of primary CNS vasculitis of childhood. AJNR Am. J. Neuroradiol. 27(1), 192-199 (2006).
78. Benedict S, Bale J, Members of the IPSS. Arterial Dissection in Childhood Stroke: Results from the International Pediatric Stroke Study (IPSS). Ann. Neurol. 62(S11), S98 (2007).
79. Rafay MF, Armstrong D, Deveber G, Domi T, Chan A, MacGregor DL. Craniocervical arterial dissection in children: clinical and radiographic presentation and outcome. J. Child. Neurol. 21(1), 8-16 (2006).
80. Yilmaz EY, Pritz MB, Bruno A, Lopez-Yunez A, Biller J. Moyamoya: Indiana University Medical Center experience. Arch. Neurol. 58(8), 1274-1278 (2001).
81. Ueki K, Meyer FB, Mellinger JF. Moyamoya disease: the disorder and surgical treatment. Mayo Clin. Proc. 69(8), 749-757 (1994).
82. Kuriyama S, Kusaka Y, Fujimura M et al. Prevalence and clinicoepidemiological features of moyamoya disease in Japan: fndings from a nationwide epidemiological survey. Stroke 39(1), 42-47 (2008).
83. Begelman SM, Olin JW. Fibromuscular dysplasia. Curr. Opin. Rheumatol. 12(1), 41-47 (2000).
84. Albayram S, Kizilkilic O, Yilmaz H, Tuysuz B, Kocer N, Islak C. Abnormalities in the cerebral arterial system in osteogenesis imperfecta. AJNR Am. J. Neuroradiol. 24(4), 748-750 (2003).
85. Friedman JM, Arbiser J, Epstein JA et al. Cardiovascular disease in neurofbromatosis 1: report of the NF1 Cardiovascular Task Force. Genet. Med. 4(3), 105-111 (2002).
86. Kirton A, DeVeber G. Ischemic stroke complicating pediatric cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 4(3), 163-166 (2007).
87. Domi T, Edgell DS, McCrindle BW et al. Frequency, predictors, and neurologic outcomes of vaso-occlusive strokes associated with cardiac surgery in children. Pediatrics 122(6), 1292-1298 (2008).
88. Chen J, Zimmerman RA, Jarvik GP et al. Perioperative stroke in infants undergoing open heart operations for congenital heart disease. Ann. Thorac. Surg. 88(3), 823-829 (2009).
89. Domi T, Edgell DS, McCrindle BW et al. Frequency and predictors of vasoocclusive strokes associated with cardiac surgery in infants and children with congenital heart disease. Ann. Neurol. 52(S3), S129 (2002).
90. Ghanayem NS, Mitchell ME, Tweddell JS, Hoffman GM. Monitoring the brain before, during, and after cardiac surgery to improve long-term neurodevelopmental outcomes. Cardiol. Young 16(Suppl. 3), 103-109 (2006).
91. Wechsler LR. PFO and stroke: what are the data? Cardiol. Rev. 16(1), 53-57 (2008).
92. Latson LA. Patent foramen ovale-'back door' to the brain, even in kids. Catheter Cardiovasc. Interv. 70(7), 1008-1009 (2007).
93. Benedik MP, Zaletel M, Meglic NP, Podnar T. Patent foramen ovale and unexplained ischemic cerebrovascular events in children. Catheter Cardiovasc. Interv. 70(7), 999-1007 (2007).
94. Gupta V, Yesilbursa D, Huang WY et al. Patent foramen ovale in a large population of ischemic stroke patients: diagnosis, age distribution, gender, and race. Echocardiography 25(2), 217-227 (2008).
95. Kenny D, Turner M, Martin R. When to close a patent foramen ovale. Arch. Dis. Child. 93(3), 255-259 (2008).
96. Wraige E, Pohl KR, Ganesan V. A proposed classifcation for subtypes of arterial ischaemic stroke in children. Dev. Med. Child. Neurol. 47(4), 252-256 (2005).
97. Earley CJ, Kittner SJ, Feeser BR et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 51(1), 169-176 (1998).
98. Ohene-Frempong K, Weiner SJ, Sleeper LA et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91(1), 288-294 (1998).
99. Dowling MM, Quinn CT, Rogers ZR, Buchanan GR. Acute silent cerebral infarction in children with sickle cell anemia. Pediatr. Blood Cancer 54(3), 461-464 (2010).
100. Pegelow CH, Macklin EA, Moser FG et al. Longitudinal changes in brain magnetic resonance imaging fndings in children with sickle cell disease. Blood 99(8), 3014-3018 (2002).
101. Bernaudin F, Verlhac S, Freard F et al. Multicenter prospective study of children with sickle cell disease: radiographic and psychometric correlation. J. Child. Neurol. 15(5), 333-343 (2000).
102. Bernaudin F, Verlhac S, Coic L, Lesprit E, Brugieres P, Reinert P. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr. Radiol. 35(3), 242-248 (2005).
103. Bader-Meunier B, Verlhac S, Elmaleh-Berges M et al. Effect of transfusion therapy on cerebral vasculopathy in children with sickle-cell anemia. Haematologica 94(1), 123-126 (2009).
104. Panigrahi I, Agarwal S. Thromboembolic complications in b-thalassemia: beyond the horizon. Thromb. Res. 120(6), 783-789 (2007).
105. Metarugcheep P, Chanyawattiwongs S, Srisubat K, Pootrakul P. Clinical silent cerebral infarct (SCI) in patients with thalassemia diseases assessed by magnetic resonance imaging (MRI). J. Med. Assoc. Thai. 91(6), 889-894 (2008).
106. Armstrong FD. Thalassemia and learning: neurocognitive functioning in children. Ann. NY Acad. Sci. 1054, 283-289 (2005).
107. Parker TM, Ward LM, Johnston DL, Ventureya E, Klaassen RJ. A case of Moyamoya syndrome and hemoglobin E/b-thalassemia. Pediatr. Blood Cancer 52(3), 422-424 (2009).
108. Goksel BK, Ozdogu H, Yildirim T, Oguzkurt L, Asma S. b-thalassemia intermedia associated with moyamoya syndrome. J. Clin. Neurosci. 17(7), 919-920 (2010).
109. Maguire JL, deVeber G, Parkin PC. Association between iron-defciency anemia and stroke in young children. Pediatrics 120(5), 1053-1057 (2007).
110. Hartfeld DS, Lowry NJ, Keene DL, Yager JY. Iron defciency: a cause of stroke in infants and children. Pediatr. Neurol. 16(1), 50-53 (1997).
111. Said JM, Brennecke SP, Moses EK et al. Ethnic differences in the prevalence of inherited thrombophilic polymorphisms in an asymptomatic Australian prenatal population. Hum. Biol. 78(4), 403-412 (2006).
112. Hoppe C, Klitz W, Cheng S et al. Gene interactions and stroke risk in children with sickle cell anemia. Blood 103(6), 2391-2396 (2004).
113. Sebastiani P, Ramoni MF, Nolan V, Baldwin CT, Steinberg MH. Genetic dissection and prognostic modeling of overt stroke in sickle cell anemia. Nat. Genet. 37(4), 435-440 (2005).
114. Kaplan P, Levinson M, Kaplan BS. Cerebral artery stenoses in Williams syndrome cause strokes in childhood. J. Pediatr. 126(6), 943-945 (1995).
115. Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 1: Fabry disease and mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Arch. Neurol. 67(1), 19-24 (2010).
116. Testai FD, Gorelick PB. Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders. Arch. Neurol. 67(2), 148-153 (2010).
117. Hartley J, Westmacott R, Decker J, Shroff M, Yoon G. Childhood-onset CADASIL: clinical, imaging, and neurocognitive features. J. Child. Neurol. 25(5), 623-627 (2010).
118. Hoppe C, Klitz W, D'Harlingue K et al. Confrmation of an association between the TNF(-308) promoter polymorphism and stroke risk in children with sickle cell anemia. Stroke 38(8), 2241-2246 (2007).
119. Mineharu Y, Liu W, Inoue K et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70(24 Pt 2), 2357-2363 (2008).
120. Hong SH, Wang KC, Kim SK, Cho BK, Park MH. Association of HLA-DR and-DQ genes with familial Moyamoya disease in Koreans. J. Korean Neurosurg. Soc. 46(6), 558-563 (2009).
121. Voetsch B, Jin RC, Bierl C et al. Promoter polymorphisms in the plasma glutathione peroxidase (GPx-3) gene: a novel risk factor for arterial ischemic stroke among young adults and children. Stroke 38(1), 41-49 (2007).
122. Shi KL, He B, Wang JJ, Zou LP. Role of TNF-a gene variation in idiopathic childhood ischemic stroke: a case-control study. J. Child. Neurol. 24(1), 25-29 (2009).
123. Wang JJ, Jiang LQ, He B, Shi KL, Li JW, Zou LP. The association of CTLA-4 and CD28 gene polymorphisms with idiopathic ischemic stroke in the paediatric population. Int. J. Immunogenet. 36(2), 113-118 (2009).
124. Lan SH, Chang WN, Lu CH, Lui CC, Chang HW. Cerebral infarction in chronic meningitis: a comparison of tuberculous meningitis and cryptococcal meningitis. Q JM 94(5), 247-253 (2001).
125. Starke JR. Tuberculosis of the central nervous system in children. Semin. Pediatr. Neurol. 6(4), 318-331 (1999).
126. Chang CJ, Chang WN, Huang LT et al. Cerebral infarction in perinatal and childhood bacterial meningitis. QJM 96(10), 755-762 (2003).
127. De Souza AL, Seguro AC. Stroke secondary to meningococcal meningitidis: a potential link between endothelial dysfunction and cytokines. Arch. Neurol. 65(2), 283-284 (2008).
128. Rodriguez-Pla A, Stone JH. Vasculitis and systemic infections. Curr. Opin. Rheumatol. 18(1), 39-47 (2006).
129. Jordan LC, van Beek JGM, Gottesman RF, Kossoff EH, Johnston M V. Ischemic Stroke in children with critical illness: a poor prognostic sign. Pediatr. Neurol. 36(4), 244-246 (2007).
130. Mallick AA, Sharples PM, Calvert SE et al. Cerebral venous sinus thrombosis: a case series including thrombolysis. Arch. Dis. Child. 94(10), 790-794 (2009).
131. Al-Jarallah A, Al-Rifai MT, Riela AR, Roach ES. Nontraumatic brain hemorrhage in children: etiology and presentation. J. Child. Neurol. 15(5), 284-289 (2000).
132. Meyer-Heim AD, Boltshauser E. Spontaneous intracranial haemorrhage in children: aetiology, presentation and outcome. Brain Dev. 25(6), 416-421 (2003).
133. Beslow LA, Licht DJ, Smith SE et al. Predictors of outcome in childhood intracerebral hemorrhage. A prospective consecutive cohort study. Stroke 41, 313-318 (2010).
134. Menovsky T, van Overbeeke JJ. Cerebral arteriovenous malformations in childhood: state of the art with special reference to treatment. Eur J. Pediatr. 156(10), 741-746 (1997).
135. Humphreys RP, Hoffman HJ, Drake JM, Rutka JT. Choices in the 1990s for the management of pediatric cerebral arteriovenous malformations. Pediatr. Neurosurg. 25(6), 277-285 (1996).
136. Fullerton HJ, Achrol AS, Johnston SC et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 36(10), 2099-2104 (2005).
137. Fleetwood IG, Steinberg GK. Arteriovenous malformations. Lancet 359(9309), 863-873 (2002).
138. Jeffree RL, Stoodley MA. Postnatal development of arteriovenous malformations. Pediatr. Neurosurg. 45(4), 296-304 (2009).
139. Mahajan A, Manchandia T, Gould G, Bulsara K. De novo arteriovenous malformations: case report and review of the literature. Neurosurg. Rev. 33(1), 115-119 (2010).
140. Stevens J, Leach JL, Abruzzo T, Jones BV. De novo cerebral arteriovenous malformation: case report and literature review. AJNR Am. J. Neuroradiol. 30(1), 111-112 (2009).
141. Revencu N, Vikkula M. Cerebral cavernous malformation: new molecular and clinical insights. J. Med. Genet. 43(9), 716-721 (2006).
142. Faurobert E, Albiges-Rizo C. Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction. FEBS J. 277(5), 1084-1096 (2010).
143. Huang J, McGirt MJ, Gailloud P, Tamargo RJ. Intracranial aneurysms in the pediatric population: case series and literature review. Surg. Neurol. 63(5), 424-432; discussion 432-1423 (2005).
144. Sharma BS, Sinha S, Mehta VS, Suri A, Gupta A, Mahapatra AK. Pediatric intracranial aneurysms-clinical characteristics and outcome of surgical treatment. Childs Nerv. Syst. 23(3), 327-333 (2007).
145. Lasjaunias P, Wuppalapati S, Alvarez H, Rodesch G, Ozanne A. Intracranial aneurysms in children aged under 15 years: review of 59 consecutive children with 75 aneurysms. Childs Nerv. Syst. 21(6), 437-450 (2005).
146. North KN, Whiteman DA, Pepin MG, Byers PH. Cerebrovascular complications in Ehlers-Danlos syndrome type IV. Ann. Neurol. 38(6), 960-964 (1995).
147. Allison JW, Davis PC, Sato Y et al. Intracranial aneurysms in infants and children. Pediatr. Radiol. 28(4), 223-229 (1998).
148. Laurent JP, Bruce DA, Schut L. Hemorrhagic brain tumors in pediatric patients. Childs Brain 8(4), 263-270 (1981).
149. Wakai S, Yamakawa K, Manaka S, Takakura K. Spontaneous intracranial hemorrhage caused by brain tumor: its incidence and clinical signifcance. Neurosurgery 10(4), 437-444 (1982).
150. Kyrnetskiy EE, Kun LE, Boop FA, Sanford RA, Khan RB. Types, causes, and outcome of intracranial hemorrhage in children with cancer. J. Neurosurg. 102(1 Suppl.), 31-35 (2005).
151. Aydinli N, Citak A, Caliskan M, Karabocuoglu M, Baysal S, Ozmen M. Vitamin K defciency-late onset intracranial haemorrhage. Eur. J. Paediatr. Neurol. 2(4), 199-203 (1998).
152. Klinge J, Auberger K, Auerswald G, Brackmann HH, Mauz-Korholz C, Kreuz W. Prevalence and outcome of intracranial haemorrhage in haemophiliacs-a survey of the paediatric group of the German Society of Thrombosis and Haemostasis (GTH). Eur J. Pediatr. 158(Suppl. 3), S162-S165 (1999).
153. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N. Engl. J. Med. 346(13), 995-1008 (2002).
154. Witmer CM, Manno CS, Butler RB, Raffni LJ. The clinical management of hemophilia and head trauma: a survey of current clinical practice among pediatric hematology/oncology physicians. Pediatr. Blood Cancer 53(3), 406-410 (2009).
155. Bolton-Maggs P. Severe bleeding in idiopathic thrombocytopenic purpura. J. Pediatr. Hematol. Oncol. 25(Suppl. 1), S47-S51 (2003).
156. Ljung RC. Intracranial haemorrhage in haemophilia A and B. Br. J. Haematol. 140(4), 378-384 (2008).
157. Psaila B, Petrovic A, Page LK, Menell J, Schonholz M, Bussel JB. Intracranial hemorrhage (ICH) in children with immune thrombocytopenia (ITP): study of 40 cases. Blood 114(23), 4777-4783 (2009).
158. Strouse JJ, Hulbert ML, DeBaun MR, Jordan LC, Casella JF. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids. Pediatrics 118(5), 1916-1924 (2006).
159. Oyesiku NM, Barrow DL, Eckman JR, Tindall SC, Colohan AR. Intracranial aneurysms in sickle-cell anemia: clinical features and pathogenesis. J. Neurosurg. 75(3), 356-363 (1991).
160. Adams RJ, Ohene-Frempong K, Wang W. Sickle cell and the brain. Hematology Am. Soc. Hematol. Educ. Program 31-46 (2001).
161. Zimmer JA, Garg BP, Williams LS, Golomb MR. Age-related variation in presenting signs of childhood arterial ischemic stroke. Pediatr. Neurol. 37(3), 171-175 (2007).
162. Braun KP, Kappelle LJ, Kirkham FJ, Deveber G. Diagnostic pitfalls in paediatric ischaemic stroke. Dev. Med. Child. Neurol. 48(12), 985-990 (2006)
163. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. Br. Med. J. 314(7088), 1151-1159 (1997).
164. Phillips RA. A review of therapeutic strategies for risk reduction of recurrent stroke. Prog. Cardiovasc. Dis. 50(4), 264-273 (2008).
165. Carpenter J, Tsuchida T, Lynch JK. Treatment of arterial ischemic stroke in children. Expert Rev. Neurother. 7(4), 383-392 (2007)
166. Paediatric Stroke Working Group. Stroke in Childhood: Clinical Guidelines for Diagnosis, Management and Rehabilitation. Royal College of Physicians, Clinical Effectiveness and Evaluation Unit, London, UK (2004).
167. Monagle P, Chalmers E, Chan A et al. Antithrombotic therapy in neonates and children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133(6 Suppl.), S887-S968 (2008).
168. Roach ES, Golomb MR, Adams R et al. Management of stroke in infants and children: a scientifc statement from a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young. Stroke 39(9), 2644-2691 (2008).
169. DeVeber G, Kirkham F. Guidelines for the treatment and prevention of stroke in children. Lancet Neurol. 7(11), 983-985 (2008).
170. Goldenberg NA, Bernard TJ, Fullerton HJ, Gordon A, deVeber G. Antithrombotic treatments, outcomes, and prognostic factors in acute childhood-onset arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 8(12), 1120-1127 (2009).
171. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med. 359(13), 1317-1329 (2008).
172. Stemer A, Lyden P. Evolution of the thrombolytic treatment window for acute ischemic stroke. Curr. Neurol. Neurosci. Rep. 10(1), 29-33 (2010).
173. Amlie-Lefond C, Benedict S, Bernard T et al. Thrombolysis in Children with Arterial Ischemic Stroke: Initial Results from the International Pediatric Stroke Study. Stroke 38(2), 485 (2007).
174. Janjua N, Nasar A, Lynch JK, Qureshi AI. Thrombolysis for ischemic stroke in children: data from the nationwide inpatient sample. Stroke 38(6), 1850-1854 (2007).
175. Amlie-Lefond C, deVeber G, Chan AK, et al. Use of alteplase in childhood arterial ischaemic stroke: a multicentre, observational, cohort study. Lancet Neurol. 8(6), 530-536 (2009).
176. Amlie-Lefond C, Chan AK, Kirton A, et al. Thrombolysis in Acute Childhood Stroke: Design and Challenges of the Thrombolysis in Pediatric Stroke Clinical Trial. Neuroepidemiology 32(4), 279-286 (2009).
177. Shi ZS, Loh Y, Walker G, Duckwiler GR. Clinical outcomes in middle cerebral artery trunk occlusions versus secondary division occlusions after mechanical thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI trials. Stroke 41(5), 953-960 (2010).
178. Penumbra Pivotal Stroke Trial Investigators. The penumbra pivotal stroke trial: safety and effectiveness of a new generation of mechanical devices for clot removal in intracranial large vessel occlusive disease. Stroke 40(8), 2761-2768 (2009).
179. Grunwald IQ, Walter S, Shamdeen MG et al. New mechanical recanalization devices-the future in pediatric stroke treatment? J. Invasive Cardiol. 22(2), 63-66 (2010).
180. Adams RJ, McKie VC, Hsu L et al. Prevention of a frst stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. N. Engl. J. Med. 339(1), 5-11 (1998).
181. Kirkham FJ, Lerner NB, Noetzel M et al. Trials in sickle cell disease. Pediatr. Neurol. 34(6), 450-458 (2006).
182. Raphael JL, Shetty PB, Liu H, Mahoney DH, Mueller BU. A critical assessment of transcranial doppler screening rates in a large pediatric sickle cell center: opportunities to improve healthcare quality. Pediatr. Blood Cancer 51(5), 647-651 (2008).
183. Armstrong-Wells J, Grimes B, Sidney S et al. Utilization of TCD screening for primary stroke prevention in children with sickle cell disease. Neurology 72(15), 1316-1321 (2009).
184. McCarville MB, Goodin GS, Fortner G et al. Evaluation of a comprehensive transcranial doppler screening program for children with sickle cell anemia. Pediatr. Blood Cancer 50(4), 818-821 (2008).
185. Fung LW, Thompson D, Ganesan V. Revascularisation surgery for paediatric Moyamoya: a review of the literature. Childs Nerv. Syst. 21(5), 358-364 (2005).
186. Benseler SM. Central nervous system vasculitis in children. Curr. Rheumatol. Rep. 8(6), 442-449 (2006).
187. Cardo E, Monros E, Colome C et al. Children with stroke: polymorphism of the MTHFR gene, mild hyperhomocysteinemia, and vitamin status. J. Child. Neurol. 15(5), 295-298 (2000).
188. Minino AM, Heron MP, Murphy SL, Kochanek KD. Deaths: fnal data for 2004. Natl Vital Stat. Rep. 55(19), 1-119 (2007).
189. Lynch JK, Hirtz DG, DeVeber G, Nelson KB. Report of the National Institute of Neurological Disorders and Stroke workshop on perinatal and childhood stroke. Pediatrics 109(1), 116-123 (2002).
190. Wraige E, Gordon A, Ganesan V. Behavioural sequelae after arterial ischaemic stroke in childhood. Dev. Med. Child. Neurol. 45(S97), 9-10 (2004).
191. Buompadre MC, Arroyo HA. Basal ganglia and internal capsule stroke in childhood-risk factors, neuroimaging, and outcome in a series of 28 patients: a tertiary hospital experience. J. Child. Neurol. 24(6), 685-691 (2009).
192. Giroud M, Lemesle M, Quantin C et al. A hospital-based and a population-based stroke registry yield different results: the experience in Dijon, France. Neuroepidemiology 16(1), 15-21 (1997).
193. Gokben S, Tosun A, Bayram N et al. Arterial ischemic stroke in childhood: risk factors and outcome in old versus new era. J. Child. Neurol. 22(10), 1204-1208 (2007).
194. DeVeber GA, MacGregor D, Curtis R, Mayank S. Neurologic outcome in survivors of childhood arterial ischemic stroke and sinovenous thrombosis. J.
195. Anderson V, Spencer-Smith M, Leventer R et al. Childhood brain insult: can age at insult help us predict outcome? Brain 132(Pt 1), 45-56 (2009).
196. Hurvitz E, Warschausky S, Berg M, Tsai S. Long-term functional outcome of pediatric stroke survivors. Top. Stroke Rehabil. 11(2), 51-59 (2004).
197. Simma B, Martin G, Muller T, Huemer M. Risk factors for pediatric stroke: consequences for therapy and quality of life. Pediatr. Neurol. 37(2), 121-126 (2007).
198. Cnossen MH, Aarsen FK, van den Akker SL et al. Paediatric arterial ischaemic stroke: functional outcome and risk factors. Dev. Med. Child. Neurol. 52(4), 394-399 (2010).
199. Westmacott R, Askalan R, Macgregor D, Anderson P, Deveber G. Cognitive outcome following unilateral arterial ischaemic stroke in childhood: effects of age at stroke and lesion location. Dev. Med. Child. Neurol. 52(4), 386-393 (2009).
200. Pavlovic J, Kaufmann F, Boltshauser E et al. Neuropsychological problems after paediatric stroke: two year follow-up of Swiss children. Neuropediatrics 37(1), 13-19 (2006).
201. Max JE, Mathews K, Lansing AE et al. Psychiatric disorders after childhood stroke. J. Am. Acad. Child. Adolesc. Psychiatry 41(5), 555-562 (2002).
202. King AA, DeBaun MR, White DA. Need for cognitive rehabilitation for children with sickle cell disease and strokes. Expert Rev. Neurother. 8(2), 291-296 (2008).
203. Kim CT, Han J, Kim H. Pediatric stroke recovery: a descriptive analysis. Arch. Phys. Med. Rehabil. 90(4), 657-662 (2009).
204. Gordon AL, Ganesan V, Towell A, Kirkham FJ. Functional outcome following stroke in children. J. Child. Neurol. 17(6), 429-434 (2002).
205. Everts R, Pavlovic J, Kaufmann F et al. Cognitive functioning, behavior, and quality of life after stroke in childhood. Child Neuropsychol. 14(4), 323-338 (2008).
206. Friefeld S, Yeboah O, Jones JE, deVeber G. Health-related quality of life and its relationship to neurological outcome in child survivors of stroke. CNS Spectr. 9(6), 465-475 (2004).
207. Jordan LC, Kleinman JT, Hillis AE. Intracerebral hemorrhage volume predicts poor neurologic outcome in children. Stroke 40(5), 1666-1671 (2009).
208. Ganesan V, Prengler M, Wade A, Kirkham FJ. Clinical and radiological recurrence after childhood arterial ischemic stroke. Circulation 114(20), 2170-2177 (2006).
209. Hoppe C. Defning stroke risk in children with sickle cell anaemia. Br. J. Haematol. 128(6), 751-766 (2005).
210. Eleftheriou D, Clarke L, Hong Y, Klein N, Ganesan V, Brogan P. Circulating endothelial cells and endothelial progenitor cells in childhood primary angiitis of the central nervous system. Pediatr. Rheumatol. 6(Suppl. 1), P276 (2008).
211. World Health Organization. International Classifcation of Functioning, Disability and Health. WHO, Geneva, Switzerland (2001).
212. World Health Organization. International Classifcation of Functioning, Disability, and Health: Children and Youth. WHO, Geneva, Switzerland (2007).
213. Mallick AA, O'Callaghan FJ. Research governance delays for a multicentre non-interventional study. J. R. Soc. Med. 102(5), 195-198 (2009).
214. The Stroke Association Manifesto 2010 to 2015. The Stroke Association, London, UK (2010). 1243-1247.